For tumor metastasis, patients with high PSMA expression were more likely to have more lymph node metastasis and distant metastasis than patients with low PSMA expression (χ2 = 4.594, P = 0.0321) (Figure 1D and Table S1). This evidence concerns the gene FOLH1 and metastatic malignant neoplasm in the lymph nodes.